234 related articles for article (PubMed ID: 25042571)
1. A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment.
Ellem SJ; Taylor RA; Furic L; Larsson O; Frydenberg M; Pook D; Pedersen J; Cawsey B; Trotta A; Need E; Buchanan G; Risbridger GP
J Pathol; 2014 Sep; 234(1):86-98. PubMed ID: 25042571
[TBL] [Abstract][Full Text] [Related]
2. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
Sauvé K; Lepage J; Sanchez M; Heveker N; Tremblay A
Cancer Res; 2009 Jul; 69(14):5793-800. PubMed ID: 19584281
[TBL] [Abstract][Full Text] [Related]
3. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
4. Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.
Rhodes LV; Antoon JW; Muir SE; Elliott S; Beckman BS; Burow ME
Mol Cancer; 2010 Nov; 9():295. PubMed ID: 21087507
[TBL] [Abstract][Full Text] [Related]
5. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer.
Bonkhoff H; Berges R
Eur Urol; 2009 Mar; 55(3):533-42. PubMed ID: 19013008
[TBL] [Abstract][Full Text] [Related]
6. A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer.
Clark AK; Taubenberger AV; Taylor RA; Niranjan B; Chea ZY; Zotenko E; Sieh S; Pedersen JS; Norden S; Frydenberg M; Grummet JP; Pook DW; ; Stirzaker C; Clark SJ; Lawrence MG; Ellem SJ; Hutmacher DW; Risbridger GP
Biomaterials; 2013 Jul; 34(20):4777-85. PubMed ID: 23562048
[TBL] [Abstract][Full Text] [Related]
7. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.
Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW
Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336
[TBL] [Abstract][Full Text] [Related]
8. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
[TBL] [Abstract][Full Text] [Related]
9. Androgen Triggers the Pro-Migratory CXCL12/CXCR4 Axis in AR-Positive Breast Cancer Cell Lines: Underlying Mechanism and Possible Implications for the Use of Aromatase Inhibitors in Breast Cancer.
Azariadis K; Kiagiadaki F; Pelekanou V; Bempi V; Alexakis K; Kampa M; Tsapis A; Castanas E; Notas G
Cell Physiol Biochem; 2017; 44(1):66-84. PubMed ID: 29131020
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer.
Heidegger I; Fotakis G; Offermann A; Goveia J; Daum S; Salcher S; Noureen A; Timmer-Bosscha H; Schäfer G; Walenkamp A; Perner S; Beatovic A; Moisse M; Plattner C; Krogsdam A; Haybaeck J; Sopper S; Thaler S; Keller MA; Klocker H; Trajanoski Z; Wolf D; Pircher A
Mol Cancer; 2022 Jun; 21(1):132. PubMed ID: 35717322
[TBL] [Abstract][Full Text] [Related]
11. Expression of oestrogen receptor-alpha and oestrogen receptor-beta in prostate cancer.
Yang GS; Wang Y; Wang P; Chen ZD
Chin Med J (Engl); 2007 Sep; 120(18):1611-5. PubMed ID: 17908481
[TBL] [Abstract][Full Text] [Related]
12. Induction of Kruppel-like factor 5 expression by androgens results in increased CXCR4-dependent migration of prostate cancer cells in vitro.
Frigo DE; Sherk AB; Wittmann BM; Norris JD; Wang Q; Joseph JD; Toner AP; Brown M; McDonnell DP
Mol Endocrinol; 2009 Sep; 23(9):1385-96. PubMed ID: 19460858
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion.
Yu S; Xia S; Yang D; Wang K; Yeh S; Gao Z; Chang C
Med Oncol; 2013; 30(3):674. PubMed ID: 23925662
[TBL] [Abstract][Full Text] [Related]
15. Progesterone reduces the migration of mast cells toward the chemokine stromal cell-derived factor-1/CXCL12 with an accompanying decrease in CXCR4 receptors.
Belot MP; Abdennebi-Najar L; Gaudin F; Lieberherr M; Godot V; Taïeb J; Emilie D; Machelon V
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1410-7. PubMed ID: 17468394
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies.
Vaday GG; Hua SB; Peehl DM; Pauling MH; Lin YH; Zhu L; Lawrence DM; Foda HD; Zucker S
Clin Cancer Res; 2004 Aug; 10(16):5630-9. PubMed ID: 15328206
[TBL] [Abstract][Full Text] [Related]
17. Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer.
Zhang S; Qi L; Li M; Zhang D; Xu S; Wang N; Sun B
J Exp Clin Cancer Res; 2008 Nov; 27(1):62. PubMed ID: 18983683
[TBL] [Abstract][Full Text] [Related]
18. Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro.
Pereira BA; Lister NL; Hashimoto K; Teng L; Flandes-Iparraguirre M; Eder A; Sanchez-Herrero A; Niranjan B;
Biomaterials; 2019 Mar; 197():72-85. PubMed ID: 30641266
[TBL] [Abstract][Full Text] [Related]
19. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo.
Sun YX; Wang J; Shelburne CE; Lopatin DE; Chinnaiyan AM; Rubin MA; Pienta KJ; Taichman RS
J Cell Biochem; 2003 Jun; 89(3):462-73. PubMed ID: 12761880
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression.
Comito G; Giannoni E; Segura CP; Barcellos-de-Souza P; Raspollini MR; Baroni G; Lanciotti M; Serni S; Chiarugi P
Oncogene; 2014 May; 33(19):2423-31. PubMed ID: 23728338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]